Subjective well-being and quality of life under atypical antipsychotic treatment.
about
Quetiapine versus other atypical antipsychotics for schizophreniaRisperidone versus other atypical antipsychotics for schizophreniaOlanzapine versus other atypical antipsychotics for schizophreniaQuetiapine versus other atypical antipsychotics for schizophreniaAre self-stigma, quality of life, and clinical data interrelated in schizophrenia spectrum patients? A cross-sectional outpatient study.The assessment of quality of life in clinical practice in patients with schizophrenia.Symptom control and patient adherence to treatment: key goals in the treatment of psychosis.Correlation between the Personal and Social Performance scale (PSP) and the Positive and Negative Syndrome Scale (PANSS) in a Greek sample of patients with schizophrenia.Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label studyDeterminants of functioning and well-being among individuals with schizophrenia: an integrated model.The impact of subjective well-being under neuroleptic treatment on compliance and remission.Current schizophrenia drugs: efficacy and side effects.Symptom domains of schizophrenia: the role of atypical antipsychotic agents.Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia.Validation of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) Among Patients with Schizophrenia.Social functioning as an outcome measure in schizophrenia studies.Quality of life, self-stigma, and hope in schizophrenia spectrum disorders: a cross-sectional study.Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review.Effectiveness studies: advantages and disadvantages.Patient Satisfaction and Quality of Life in People with Schizophrenia-Spectrum Disorders in a Rural Area.Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis.Correlation between changes in quality of life and symptomatic improvement in Chinese patients switched from typical antipsychotics to olanzapine.Antipsychotic agents: efficacy and safety in schizophreniaEffectiveness, tolerability and subjective well-being in patients receiving quetiapine: findings of a post-marketing surveillance study in schizophrenia.Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients.Adverse effects of atypical antipsychotic agents and their effects on quality of life.Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria.Atypical anti-psychotics in the real world--a naturalistic comparative outcome study.Impaired subjective well-being in schizophrenia is associated with reduced anterior cingulate activity during reward processing.Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial.Investigation into effects of antipsychotics on ectonucleotidase and adenosine deaminase in zebrafish brain.Hypofrontality in schizophrenic patients and its relevance for the choice of antipsychotic medication: an event-related potential study.Relationship between improvements of subjective well-being and depressive symptoms during acute treatment of schizophrenia with atypical antipsychotics.Quality of life in schizophrenia on conventional versus atypical antipsychotic medication: a comparative cross-sectional study.International schizophrenia research and the concept of patient-centredness: an analysis over two decades.Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
P2860
Q24202427-D2A5AE6E-FB71-46B3-8D73-99ACB8DF7AD3Q24234950-57EACB5C-773D-44EB-8EE0-29C0AFC5348CQ24236545-7F928718-1268-45F1-A722-A217FD263FCBQ24240989-95FBC0E6-947A-4EA8-A450-C30879210649Q31064023-7FF1EA26-94CB-497D-840F-72E1B3F62C5BQ34074662-E9044661-C032-4EEE-938B-7165B045C891Q34450843-B9F1840C-4FC2-4184-9CC4-C4B63DF038A4Q34485509-B7ED664A-6B88-4D5C-89AC-DB2EC66FCFD1Q35191252-6DE59BAA-D32F-4899-8EB2-060444BA1637Q35623422-F3192F89-A676-4D59-ACCC-388EDE58E3B2Q36460707-34785FE2-0F52-492F-8E7F-F43935043EEEQ36488206-F03146C1-0622-4F7C-B339-9B94FEB63B8EQ36626242-F9A08A7F-49FA-4A4D-B128-4D62686E2A29Q36825043-BC968028-A373-4240-9093-508959C0F199Q36945033-089ADEA8-5269-4953-9B3F-25DF8C0DE358Q36973846-B5155FF0-3571-4BA8-B99F-3197BEFD9A4CQ37669893-55FA921D-82DD-4E6F-B05D-83BF9920D4DFQ37857856-A69D8A0B-7932-4356-9152-C7989CD731ABQ37917728-985CEEE6-CE7C-41A6-AE46-3D8005F2E78DQ38653270-7407A167-1E1E-44B9-876D-C15EF4CF9EEEQ40254338-0A906B6B-B19A-4E1E-BB08-107B659E25D2Q41510821-370AD6A0-AD1E-4284-8B4E-B8E0604DC4B7Q41957512-0C90D169-F064-4E83-9D9C-2B3F7DA73BCDQ42666932-43D20BE6-3606-430B-A915-8D79285404A0Q43052665-6395388D-9CF5-41F3-B202-7E24039199EEQ45013063-DAC9D8B0-34DD-4474-8D0F-4A55A198B294Q45080426-01159FF1-6AEA-4EE6-BC41-36F1AB3D160AQ46704297-C1F0B95B-192C-4C78-9940-5EF84C60E5F8Q47744849-47E6E401-26AF-46FC-A1C5-5A5F431563C7Q48076232-D6AB18C9-44E1-49A5-B4E8-2C95CC7DCD85Q48089404-FC1C604B-BF88-40D4-B652-94DACF59E9A7Q48684926-13A42A6F-941D-431D-9D00-C2CE86AB1BA1Q48900090-9FE26065-39C6-4B39-B53F-F388D16BF567Q51915956-BF113B43-BA25-4E46-B08D-2BC8E1D17197Q53113901-82E51C4E-BDA6-4497-BE1B-DE278D29169CQ55499428-D9406622-540A-472A-9BD0-C87231C43DB9
P2860
Subjective well-being and quality of life under atypical antipsychotic treatment.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Subjective well-being and quality of life under atypical antipsychotic treatment.
@ast
Subjective well-being and quality of life under atypical antipsychotic treatment.
@en
Subjective well-being and quality of life under atypical antipsychotic treatment.
@nl
type
label
Subjective well-being and quality of life under atypical antipsychotic treatment.
@ast
Subjective well-being and quality of life under atypical antipsychotic treatment.
@en
Subjective well-being and quality of life under atypical antipsychotic treatment.
@nl
prefLabel
Subjective well-being and quality of life under atypical antipsychotic treatment.
@ast
Subjective well-being and quality of life under atypical antipsychotic treatment.
@en
Subjective well-being and quality of life under atypical antipsychotic treatment.
@nl
P1433
P1476
Subjective well-being and quality of life under atypical antipsychotic treatment.
@en
P2888
P356
10.1007/S00213-002-1052-Z
P577
2002-04-20T00:00:00Z
P6179
1051497566